Exodus Point Capital Management, LP Vincerx Pharma, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Vincerx Pharma, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 316,642 shares of VINC stock, worth $234,315. This represents 0.01% of its overall portfolio holdings.
Number of Shares
316,642
Previous 389,512
18.71%
Holding current value
$234,315
Previous $393,000
307.63%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VINC
# of Institutions
39Shares Held
8.46MCall Options Held
0Put Options Held
0-
Sage Rhino Capital LLC1.7MShares$1.26 Million2.1% of portfolio
-
Octagon Capital Advisors LP New York, NY1MShares$740,0000.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct955KShares$706,5710.01% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD892KShares$659,8720.12% of portfolio
-
Bank Of America Corp Charlotte, NC701KShares$519,0530.0% of portfolio
About Vincerx Pharma, Inc.
- Ticker VINC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,189,800
- Market Cap $15.7M
- Description
- Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...